CRONOS GROUP INC. Increase (Decrease) in Accrued Interest Receivable, Net
CRONOS GROUP INC. (CRON) reported Increase (Decrease) in Accrued Interest Receivable, Net of -$3.57 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet · last filed 2026-08-06
- CRONOS GROUP INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2026-06-30 was -$1.21M.
- CRONOS GROUP INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2026-03-31 was -$2.36M.
- CRONOS GROUP INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2025-12-31 was $2.11M, a 20.17% decline year-over-year.
- CRONOS GROUP INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2025-09-30 was $4.14M, a 89.10% increase year-over-year.
- CRONOS GROUP INC. increase (decrease) in accrued interest receivable, net for fiscal 2025 was $11.00K, a 99.70% decline from fiscal 2024.
- CRONOS GROUP INC. increase (decrease) in accrued interest receivable, net for fiscal 2024 was $3.66M, a 74.51% decline from fiscal 2023.
- CRONOS GROUP INC. increase (decrease) in accrued interest receivable, net for fiscal 2023 was $14.34M, a 105.35% increase from fiscal 2022.
- CRONOS GROUP INC. increase (decrease) in accrued interest receivable, net for fiscal 2022 was $6.99M, a 179.74% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Interest Receivable, Net 3 month | Increase (Decrease) in Accrued Interest Receivable, Net 6 month | Increase (Decrease) in Accrued Interest Receivable, Net 6 month as first filed | Increase (Decrease) in Accrued Interest Receivable, Net 9 month | Increase (Decrease) in Accrued Interest Receivable, Net 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$3.57M 10-Q · filed 2026-08-06 | -$1.46M derived: sum of 3 quarters · filed 2026-08-06 | $2.68M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$2.36M 10-Q · filed 2026-05-11 | -$254.00K derived: sum of 2 quarters · filed 2026-05-11 | $3.89M derived: sum of 3 quarters · filed 2026-05-11 | $1.10M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.25M derived: sum of 2 quarters · filed 2026-02-26 | $3.46M derived: sum of 3 quarters · filed 2026-08-06 | $11.00K 10-K · filed 2026-02-26 | |
| 2025-09-30 | $4.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.36M derived: sum of 2 quarters · filed 2026-08-06 | -$2.10M 10-Q · filed 2025-11-06 | $543.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$6.24M 10-Q · filed 2026-08-06 | -$3.60M derived: sum of 3 quarters · filed 2026-08-06 | -$1.41M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | -$3.45M 10-Q · filed 2026-05-11 | -$815.00K derived: sum of 2 quarters · filed 2026-05-11 | $1.38M derived: sum of 3 quarters · filed 2026-05-11 | $4.45M derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | $2.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.83M derived: sum of 2 quarters · filed 2026-02-26 | $7.91M derived: sum of 3 quarters · filed 2026-02-26 | $3.66M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $5.27M derived: sum of 2 quarters · filed 2025-11-06 | $1.02M 10-Q · filed 2025-11-06 | $761.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $3.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.17M 10-Q · filed 2025-08-07 | -$1.43M derived: sum of 3 quarters · filed 2026-02-26 | $2.93M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | -$4.25M 10-Q · filed 2025-05-08 | -$4.51M derived: sum of 2 quarters · filed 2026-02-26 | -$150.00K derived: sum of 3 quarters · filed 2026-02-26 | $8.14M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | -$257.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.10M derived: sum of 2 quarters · filed 2026-02-26 | $12.39M derived: sum of 3 quarters · filed 2026-02-26 | $14.34M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $4.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $12.65M derived: sum of 2 quarters · filed 2024-11-12 | $14.60M 10-Q · filed 2024-11-12 | $16.25M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $8.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $10.24M 10-Q · filed 2024-08-08 | $6.81M 10-Q · filed 2023-08-08 | $11.90M derived: sum of 3 quarters · filed 2025-02-27 | $16.84M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $1.95M 10-Q · filed 2024-05-09 | $3.61M derived: sum of 2 quarters · filed 2025-02-27 | $8.55M derived: sum of 3 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $6.60M derived: sum of 2 quarters · filed 2025-02-27 | $6.99M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $4.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $5.33M 10-Q · filed 2023-11-08 | |||
| 2022-06-30 | $383.00K 10-Q · filed 2023-08-08 | ||||
| 2021-12-31 | $2.50M 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |